Xu Li - Search Results

Year	Number of Results
1996	3
1999	1
2000	2
2002	30
2003	31
2004	57
2005	72
2006	80
2007	98
2008	136
2009	151
2010	181
2011	191
2012	234
2013	255
2014	300
2015	375
2016	376
2017	368
2018	407
2019	457
2020	547
2021	655
2022	728
2023	734
2024	263

1

Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma.

Wu RQ, Lao XM, Chen DP, Qin H, Mu M, Cao WJ, Deng J, Wan CC, Zhan WY, Wang JC, Xu L, Chen MS, Gao Q, Zheng L, Wei Y, Kuang DM. Wu RQ, et al. Among authors: xu l. Immunity. 2023 Jan 10;56(1):180-192.e11. doi: 10.1016/j.immuni.2022.11.014. Epub 2022 Dec 22. Immunity. 2023. PMID: 36563676

2

Evolutionary analysis of a complete chicken genome.

Huang Z, Xu Z, Bai H, Huang Y, Kang N, Ding X, Liu J, Luo H, Yang C, Chen W, Guo Q, Xue L, Zhang X, Xu L, Chen M, Fu H, Chen Y, Yue Z, Fukagawa T, Liu S, Chang G, Xu L. Huang Z, et al. Among authors: xu l. Proc Natl Acad Sci U S A. 2023 Feb 21;120(8):e2216641120. doi: 10.1073/pnas.2216641120. Epub 2023 Feb 13. Proc Natl Acad Sci U S A. 2023. PMID: 36780517 Free PMC article.

3

NamiRNA-enhancer network of miR-492 activates the NR2C1-TGF-β/Smad3 pathway to promote epithelial-mesenchymal transition of pancreatic cancer.

Liu S, He X, Di Y, Li Q, Li F, Ma Y, Chen L, Gao Y, Xu J, Yang S, Xu L, Corpe C, Ling Y, Zhang X, Xu J, Yu W, Wang J. Liu S, et al. Among authors: xu l. Carcinogenesis. 2023 May 26;44(2):153-165. doi: 10.1093/carcin/bgac102. Carcinogenesis. 2023. PMID: 36591938

4

Enhancement of glycolysis-dependent DNA repair regulated by FOXO1 knockdown via PFKFB3 attenuates hyperglycemia-induced endothelial oxidative stress injury.

Sun D, Chen S, Li S, Wang N, Zhang S, Xu L, Zhu S, Li H, Gu Q, Xu X, Wei F. Sun D, et al. Among authors: xu l. Redox Biol. 2023 Feb;59:102589. doi: 10.1016/j.redox.2022.102589. Epub 2022 Dec 25. Redox Biol. 2023. PMID: 36577299 Free PMC article.

5

Epigenetic modification in Parkinson's disease.

Song H, Chen J, Huang J, Sun P, Liu Y, Xu L, Wei C, Mu X, Lu X, Wang W, Zhang N, Shang M, Mo M, Zhang W, Zhao H, Han F. Song H, et al. Among authors: xu l. Front Cell Dev Biol. 2023 Jun 7;11:1123621. doi: 10.3389/fcell.2023.1123621. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37351278 Free PMC article. Review.

6

Regulatory T cells alleviate myelin loss and cognitive dysfunction by regulating neuroinflammation and microglial pyroptosis via TLR4/MyD88/NF-κB pathway in LPC-induced demyelination.

Wang Y, Sadike D, Huang B, Li P, Wu Q, Jiang N, Fang Y, Song G, Xu L, Wang W, Xie M. Wang Y, et al. Among authors: xu l. J Neuroinflammation. 2023 Feb 18;20(1):41. doi: 10.1186/s12974-023-02721-0. J Neuroinflammation. 2023. PMID: 36803990 Free PMC article.

7

Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases.

Xu L, Xu H, Chen S, Jiang W, Afridi SK, Wang Y, Ren X, Zhao Y, Lai S, Qiu X, Alvin Huang YW, Cui Y, Yang H, Qiu W, Tang C. Xu L, et al. Mol Ther. 2023 Sep 6;31(9):2715-2733. doi: 10.1016/j.ymthe.2023.07.017. Epub 2023 Jul 22. Mol Ther. 2023. PMID: 37481702

8

CHI3L1 signaling impairs hippocampal neurogenesis and cognitive function in autoimmune-mediated neuroinflammation.

Jiang W, Zhu F, Xu H, Xu L, Li H, Yang X, Khan Afridi S, Lai S, Qiu X, Liu C, Li H, Long Y, Wang Y, Connolly K, Elias JA, Lee CG, Cui Y, Huang YA, Qiu W, Tang C. Jiang W, et al. Among authors: xu l. Sci Adv. 2023 Sep 29;9(39):eadg8148. doi: 10.1126/sciadv.adg8148. Epub 2023 Sep 27. Sci Adv. 2023. PMID: 37756391 Free PMC article.

9

Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma.

Xu L, Wang Y, Wang G, Guo S, Yu D, Feng Q, Hu K, Chen G, Li B, Xu Z, Jia X, Lu Y, Zhang H, Gao X, Chang S, Wang H, Wu X, Song D, Yang G, Zhu H, Zhou J, Zhan F, Zhu W, Shi J. Xu L, et al. Leukemia. 2023 Jul;37(7):1576-1579. doi: 10.1038/s41375-023-01925-w. Epub 2023 May 8. Leukemia. 2023. PMID: 37157015 No abstract available.

10

Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors.

Su X, Lu X, Bazai SK, Dainese L, Verschuur A, Dumont B, Mouawad R, Xu L, Cheng W, Yan F, Irtan S, Lindner V, Paillard C, Le Bouc Y, Coulomb A, Malouf GG. Su X, et al. Among authors: xu l. Nat Commun. 2023 Nov 30;14(1):7884. doi: 10.1038/s41467-023-43290-3. Nat Commun. 2023. PMID: 38036539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

5,955 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

5,955 results

Results by year